Detalhe da pesquisa
1.
Role of the integrin-linked kinase/TGF-ß/SMAD pathway in sitagliptin-mediated cardioprotective effects in a rat model of diabetic cardiomyopathy.
J Pharm Pharmacol
; 76(1): 64-73, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992247